AU2017318674B2 - CXCR3 receptor agonists - Google Patents
CXCR3 receptor agonists Download PDFInfo
- Publication number
- AU2017318674B2 AU2017318674B2 AU2017318674A AU2017318674A AU2017318674B2 AU 2017318674 B2 AU2017318674 B2 AU 2017318674B2 AU 2017318674 A AU2017318674 A AU 2017318674A AU 2017318674 A AU2017318674 A AU 2017318674A AU 2017318674 B2 AU2017318674 B2 AU 2017318674B2
- Authority
- AU
- Australia
- Prior art keywords
- structure cpd
- compound
- cpd
- mmol
- dcm
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Neurosurgery (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662383202P | 2016-09-02 | 2016-09-02 | |
| US62/383,202 | 2016-09-02 | ||
| US201762478496P | 2017-03-29 | 2017-03-29 | |
| US62/478,496 | 2017-03-29 | ||
| PCT/US2017/049768 WO2018045246A1 (en) | 2016-09-02 | 2017-08-31 | Cxcr3 receptor agonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2017318674A1 AU2017318674A1 (en) | 2019-03-28 |
| AU2017318674B2 true AU2017318674B2 (en) | 2020-11-12 |
Family
ID=59846729
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2017318674A Ceased AU2017318674B2 (en) | 2016-09-02 | 2017-08-31 | CXCR3 receptor agonists |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20190345133A1 (OSRAM) |
| EP (1) | EP3507275B1 (OSRAM) |
| JP (1) | JP7181857B2 (OSRAM) |
| AU (1) | AU2017318674B2 (OSRAM) |
| CA (1) | CA3034108A1 (OSRAM) |
| ES (1) | ES2950560T3 (OSRAM) |
| MX (1) | MX380217B (OSRAM) |
| WO (1) | WO2018045246A1 (OSRAM) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021163272A2 (en) | 2020-02-12 | 2021-08-19 | The Regents Of The University Of California | Platelet factors and cognitive improvement |
| CN111943823A (zh) * | 2020-09-16 | 2020-11-17 | 安徽工业大学 | 一种苯菌酮的制备方法 |
| CN116178383B (zh) * | 2022-12-26 | 2025-04-22 | 南方科技大学 | 生物碱及三价铁卟啉催化合成生物碱的方法 |
-
2017
- 2017-08-31 AU AU2017318674A patent/AU2017318674B2/en not_active Ceased
- 2017-08-31 MX MX2019002166A patent/MX380217B/es unknown
- 2017-08-31 WO PCT/US2017/049768 patent/WO2018045246A1/en not_active Ceased
- 2017-08-31 ES ES17765033T patent/ES2950560T3/es active Active
- 2017-08-31 CA CA3034108A patent/CA3034108A1/en not_active Abandoned
- 2017-08-31 EP EP17765033.0A patent/EP3507275B1/en active Active
- 2017-08-31 US US16/335,641 patent/US20190345133A1/en not_active Abandoned
- 2017-08-31 JP JP2019512307A patent/JP7181857B2/ja active Active
-
2020
- 2020-05-11 US US16/872,161 patent/US11040954B1/en active Active
Non-Patent Citations (3)
| Title |
|---|
| BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, vol. 349, no. 1, pages 221 - 228 * |
| BRITISH JOURNAL OF PHARMACOLOGY, 2012, vol. 166, no. 3, pages 898 - 911 * |
| JOURNAL OF MEDICINAL CHEMISTRY, 2012, vol. 55, no. 23, pages 10572 - 10583 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CA3034108A1 (en) | 2018-03-08 |
| ES2950560T3 (es) | 2023-10-11 |
| US11040954B1 (en) | 2021-06-22 |
| MX380217B (es) | 2025-03-12 |
| EP3507275A1 (en) | 2019-07-10 |
| AU2017318674A1 (en) | 2019-03-28 |
| JP7181857B2 (ja) | 2022-12-01 |
| EP3507275B1 (en) | 2023-04-26 |
| MX2019002166A (es) | 2019-06-12 |
| US20190345133A1 (en) | 2019-11-14 |
| JP2019533639A (ja) | 2019-11-21 |
| WO2018045246A1 (en) | 2018-03-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6983273B2 (ja) | リジン特異的なデメチラーゼ−１の阻害剤 | |
| CN111278825B (zh) | 二氮杂螺rock抑制剂 | |
| ES2698998T3 (es) | Compuestos tricíclicos como agentes antineoplásicos | |
| JP6404838B2 (ja) | ブロモドメイン阻害剤として有用なカルバゾール化合物 | |
| ES2898698T3 (es) | Salicilamidas de espiroheptanos y compuestos relacionados como inhibidores de cinasa Rho (ROCK) | |
| AU2016371014B2 (en) | Polycyclic TLR7/8 antagonists and use thereof in the treatment of immune disorders | |
| ES2785498T3 (es) | Ftalazinonas e isoquinolinonas como inhibidores de ROCK | |
| US9751879B2 (en) | Tricyclic compounds as anticancer agents | |
| JP2024523657A (ja) | ホスファターゼ分解剤の合成及び応用 | |
| AU2018321291A1 (en) | Benzosulfonyl compounds | |
| MX2014009281A (es) | Prolinas/piperidinas sustituidas como antagonistas del receptor de orexina. | |
| CN110869361B (zh) | 用于治疗心力衰竭的rock的五元氨基杂环和5,6元或6,6元双环氨基杂环抑制剂 | |
| MX2008008866A (es) | Compuestos para inhibicion de integrinas y su uso. | |
| BR112015012571A2 (pt) | compostos de imidazopiridina | |
| TW200808707A (en) | Sulfamide and sulfamate derivatives as histone deacetylase inhibitors | |
| TWI816704B (zh) | 苯并咪唑衍生物及其用途 | |
| AU2017318674B2 (en) | CXCR3 receptor agonists | |
| CA2965523A1 (en) | Carbazole derivatives | |
| EA038173B1 (ru) | Терапевтические соединения в качестве ингибиторов рецептора орексина-1 | |
| EP2976077A1 (en) | Substituted benzimidazoles as nociceptin receptor modulators | |
| CA2973773A1 (en) | 2-phenyl-3h-imidazo[4,5-b]pyridine derivatives useful as inhibitors of mammalian tyrosine kinase ror1 activity | |
| KR20220136395A (ko) | Irak4 억제제로서 유용한 트리시클릭 헤테로아릴 화합물 | |
| US20250129070A1 (en) | Bifunctional androgen receptor compounds | |
| WO2025170939A1 (en) | Proteasome inhibitors for the treatment of malaria | |
| WO2025114399A1 (en) | Flavivirus inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC1 | Assignment before grant (sect. 113) |
Owner name: RECEPTOS LLC Free format text: FORMER APPLICANT(S): CELGENE INTERNATIONAL II SARL |
|
| FGA | Letters patent sealed or granted (standard patent) | ||
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |